Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$272M |
| 2 |
Chevron
CVX
|
+$206M |
| 3 |
Tesla
TSLA
|
+$153M |
| 4 |
NVIDIA
NVDA
|
+$143M |
| 5 |
Pfizer
PFE
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$242M |
| 2 |
First Solar
FSLR
|
+$153M |
| 3 |
Walmart Inc
WMT
|
+$133M |
| 4 |
Steel Dynamics
STLD
|
+$115M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.92% |
| 2 | Financials | 15.55% |
| 3 | Industrials | 13.68% |
| 4 | Consumer Discretionary | 11.04% |
| 5 | Healthcare | 10.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABST
2976
DELISTED
Absolute Software Corp
ABST
| $763K | ﹤0.01% |
66,572
+9,578
| +17% | +$95.9K |
|
2977
Auburn National Bancorp
AUBN
$91.3M
| $755K | ﹤0.01% |
35,229
+632
| +2% | +$13.8K |
|
2978
Atlantic American Corp
AAME
$32.4M
| $755K | ﹤0.01% |
391,219
-53,550
| -12% | -$119K |
|
2979
Cytokinetics
CYTK
$10.6B
| $754K | ﹤0.01% |
23,126
+419
| +2% | +$15.5K |
|
2980
Bioceres Crop Solutions
BIOX
$22M
| $754K | ﹤0.01% |
56,453
| – | – |
|
|
EGIO
2981
DELISTED
Edgio, Inc. Common Stock
EGIO
| $754K | ﹤0.01% |
27,941
-17,518
| -39% | -$414K |
|
2982
CPI Card Group
PMTS
$237M
| $752K | ﹤0.01% |
32,338
+11,691
| +57% | +$374K |
|
2983
Live Ventures
LIVE
$29.8M
| $749K | ﹤0.01% |
28,090
-1,340
| -5% | -$37.8K |
|
2984
Cumberland Pharmaceuticals
CPIX
$98.4M
| $746K | ﹤0.01% |
507,290
-101,743
| -17% | -$176K |
|
2985
Theravance Biopharma
TBPH
$874M
| $741K | ﹤0.01% |
+71,604
| New | +$791K |
|
2986
Rocky Mountain Chocolate Factory
RMCF
$8.02M
| $740K | ﹤0.01% |
136,847
-200
| -0.1% | -$1.07K |
|
|
THRX
2987
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $737K | ﹤0.01% |
+78,993
| New | +$778K |
|
2988
Vaalco Energy
EGY
$574M
| $734K | ﹤0.01% |
195,165
-645,789
| -77% | -$2.64M |
|
|
HCP
2989
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $729K | ﹤0.01% |
27,848
+18,760
| +206% | +$550K |
|
|
CLPR
2990
Clipper Realty
CLPR
$44.9M
| $725K | ﹤0.01% |
127,956
+1,829
| +1% | +$9.96K |
|
2991
C4 Therapeutics
CCCC
$387M
| $724K | ﹤0.01% |
263,384
-118,832
| -31% | -$382K |
|
2992
EverCommerce
EVCM
$2.16B
| $723K | ﹤0.01% |
61,066
+13,865
| +29% | +$162K |
|
|
AMPS
2993
DELISTED
Altus Power
AMPS
| $719K | ﹤0.01% |
+133,024
| New | +$656K |
|
2994
TPG
TPG
$6.99B
| $716K | ﹤0.01% |
24,468
+1,914
| +8% | +$53.7K |
|
2995
Bluerock Homes Trust
BHM
$35.2M
| $711K | ﹤0.01% |
44,071
| – | – |
|
|
AZUL
2996
DELISTED
Azul
AZUL
| $711K | ﹤0.01% |
53,018
-1,838
| -3% | -$16.7K |
|
2997
Dakota Gold
DC
$608M
| $710K | ﹤0.01% |
243,167
+136,714
| +128% | +$450K |
|
2998
Canadian Solar
CSIQ
$1.02B
| $696K | ﹤0.01% |
17,999
+528
| +3% | +$20.5K |
|
2999
Fidelity D&D Bancorp
FDBC
$304M
| $696K | ﹤0.01% |
14,323
| – | – |
|
3000
Golar LNG
GLNG
$4.99B
| $694K | ﹤0.01% |
34,429
| – | – |
|
Similar funds
Dimensional Fund Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Dimensional Fund Advisors held 3,572 positions worth $314B, up 5.7% from $297B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Dimensional Fund Advisors's Q2 2023 filing shows 111 new, 1,840 increased, 1,366 reduced and 91 closed positions. Its largest new stake was Knife River: 1,268,239 shares worth $55.2M. The largest sale was Apple, an estimated $242M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2023 buy was Knife River: 1,268,239 shares worth $55.2M.
- Dimensional Fund Advisors added most to ExxonMobil in Q2 2023, an estimated $272M increase.
- Dimensional Fund Advisors's biggest Q2 2023 reduction was Apple, cutting an estimated $242M.
- Dimensional Fund Advisors fully exited Maxar Technologies Inc. Common Stock in Q2 2023, selling an estimated $102M.
- Dimensional Fund Advisors's ten largest holdings make up 12% of its $314B portfolio in Q2 2023.
- Dimensional Fund Advisors opened 111 new positions and closed 91 in Q2 2023.
- Dimensional Fund Advisors's portfolio value rose 5.7% quarter-over-quarter to $314B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.